The Upside – EDBI E-Newsletter 2022 Q4
Reflecting on the year and new developments in Q4
Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion
The latest round of funding was led by Patient Square Capital and included participation from EDBI, PS Capital, Alafi Capital, and NRW.BANK, as well as other existing investors.
The Upside – EDBI E-Newsletter 2022 Q3
Presenting new developments in Q3
Fazz Secures $100M in Series C to Power Financial Inclusion in SEA
Fresh investment from prominent investors will propel Fazz into a new season of growth and further accelerate the future of Business Finance in Southeast Asia.
The Sustainable Recipe to Feed the World
Dive into China and Southeast Asia’s agrifood landscape, and what the future holds
The Perks of Investing in Real Time Data
A video interview by Singapore Business Review featuring Deb Dutta (DataStax) and Paul Ng (EDBI) on how real time data applications can help organisations innovate and adopt next generation technologies to build a smarter Singapore.
Pindrop Continues to Grow, Expands its Footprint into APAC
Pindrop, a global technology leader offering security, identity, and intelligence for every voice, today announced its expansion into the Asia-Pacific region, with entry into Singapore as its first move.
The Upside – EDBI E-Newsletter 2022 Q2
We continue to focus on value creation efforts for our portfolio companies.
DataStax Secures $115 Million Investment led by Goldman Sachs Asset Management
DataStax, the real-time data company, announced that it has secured $115 million in funding led by the Growth Equity business within Goldman Sachs, with participation from Rokos Capital and Singapore-based global investor EDBI.
Tessa Therapeutics Completes US$126 Million Financing Led by Polaris Partners
Tessa Therapeutics, a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the close of a US$126 million Series A financing round.
